 Se-Ran Jun
Concepts (167)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Viral | 5 | 2019 | 79 | 1.480 |
Why?
| | Genomics | 7 | 2023 | 279 | 1.410 |
Why?
| | Phylogeny | 12 | 2022 | 236 | 1.170 |
Why?
| | Genome, Bacterial | 6 | 2022 | 124 | 1.060 |
Why?
| | Enterococcus faecium | 1 | 2023 | 2 | 0.850 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2022 | 27 | 0.800 |
Why?
| | Daptomycin | 1 | 2022 | 29 | 0.790 |
Why?
| | Cross Infection | 1 | 2023 | 94 | 0.790 |
Why?
| | Bacteremia | 1 | 2022 | 89 | 0.750 |
Why?
| | Microcephaly | 2 | 2018 | 41 | 0.710 |
Why?
| | Mumps virus | 1 | 2019 | 11 | 0.650 |
Why?
| | Mumps | 1 | 2019 | 13 | 0.650 |
Why?
| | Genetic Variation | 3 | 2017 | 207 | 0.620 |
Why?
| | Disease Outbreaks | 1 | 2019 | 120 | 0.610 |
Why?
| | Bacteria | 3 | 2018 | 218 | 0.600 |
Why?
| | Proteome | 3 | 2025 | 169 | 0.580 |
Why?
| | Metagenomics | 2 | 2015 | 42 | 0.520 |
Why?
| | Pseudomonas | 1 | 2015 | 7 | 0.510 |
Why?
| | Populus | 1 | 2015 | 8 | 0.510 |
Why?
| | Ebolavirus | 1 | 2015 | 7 | 0.500 |
Why?
| | Metagenome | 1 | 2015 | 40 | 0.500 |
Why?
| | Algorithms | 2 | 2017 | 625 | 0.490 |
Why?
| | Microbial Sensitivity Tests | 3 | 2024 | 269 | 0.440 |
Why?
| | Neoplasms | 1 | 2023 | 1251 | 0.420 |
Why?
| | Drug Resistance, Microbial | 2 | 2023 | 45 | 0.410 |
Why?
| | Kidney Transplantation | 2 | 2025 | 189 | 0.400 |
Why?
| | Anti-Bacterial Agents | 4 | 2024 | 745 | 0.350 |
Why?
| | Prokaryotic Cells | 1 | 2009 | 7 | 0.340 |
Why?
| | Sequence Analysis, Protein | 1 | 2009 | 19 | 0.340 |
Why?
| | Proteomics | 2 | 2025 | 314 | 0.320 |
Why?
| | Pseudomonas aeruginosa | 2 | 2022 | 72 | 0.310 |
Why?
| | Sequence Analysis, DNA | 4 | 2016 | 226 | 0.300 |
Why?
| | Organ Preservation | 2 | 2025 | 30 | 0.290 |
Why?
| | Cephalosporins | 2 | 2024 | 39 | 0.270 |
Why?
| | Evolution, Molecular | 3 | 2019 | 95 | 0.270 |
Why?
| | DNA Transposable Elements | 2 | 2024 | 103 | 0.250 |
Why?
| | Arkansas | 2 | 2023 | 1985 | 0.240 |
Why?
| | Genome | 3 | 2009 | 65 | 0.240 |
Why?
| | Weightlessness Simulation | 1 | 2025 | 22 | 0.240 |
Why?
| | Cosmic Radiation | 1 | 2025 | 34 | 0.230 |
Why?
| | Phosphoproteins | 1 | 2025 | 115 | 0.230 |
Why?
| | Acinetobacter Infections | 1 | 2024 | 8 | 0.230 |
Why?
| | Carbapenems | 1 | 2024 | 16 | 0.230 |
Why?
| | Acinetobacter baumannii | 1 | 2024 | 12 | 0.230 |
Why?
| | Metabolomics | 1 | 2025 | 135 | 0.220 |
Why?
| | Codon | 3 | 2019 | 44 | 0.220 |
Why?
| | Doxorubicin | 1 | 2025 | 236 | 0.220 |
Why?
| | Kidney | 2 | 2025 | 696 | 0.210 |
Why?
| | Sex Characteristics | 1 | 2025 | 198 | 0.210 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2024 | 116 | 0.210 |
Why?
| | Enterococcus | 1 | 2022 | 10 | 0.200 |
Why?
| | Klebsiella Infections | 1 | 2022 | 12 | 0.200 |
Why?
| | Klebsiella pneumoniae | 1 | 2022 | 20 | 0.200 |
Why?
| | Polymyxin B | 1 | 2021 | 5 | 0.190 |
Why?
| | Epigenesis, Genetic | 1 | 2025 | 372 | 0.190 |
Why?
| | Humans | 13 | 2025 | 50503 | 0.190 |
Why?
| | Vegetables | 1 | 2021 | 63 | 0.180 |
Why?
| | Lung | 1 | 2025 | 504 | 0.180 |
Why?
| | Inpatients | 1 | 2022 | 193 | 0.180 |
Why?
| | Sulfoxides | 1 | 2020 | 21 | 0.180 |
Why?
| | Genotype | 2 | 2019 | 533 | 0.180 |
Why?
| | Isothiocyanates | 1 | 2020 | 19 | 0.180 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2020 | 40 | 0.170 |
Why?
| | Databases, Genetic | 2 | 2017 | 88 | 0.170 |
Why?
| | Hepatitis A virus | 1 | 2019 | 3 | 0.170 |
Why?
| | Caregivers | 1 | 2022 | 217 | 0.170 |
Why?
| | Hepatitis E virus | 1 | 2019 | 9 | 0.170 |
Why?
| | Mumps Vaccine | 1 | 2019 | 6 | 0.170 |
Why?
| | Neutralization Tests | 1 | 2019 | 23 | 0.160 |
Why?
| | Antibodies, Neutralizing | 1 | 2019 | 62 | 0.160 |
Why?
| | Preservation, Biological | 1 | 2018 | 8 | 0.160 |
Why?
| | Antibodies, Viral | 1 | 2019 | 94 | 0.160 |
Why?
| | Hepacivirus | 1 | 2019 | 105 | 0.160 |
Why?
| | Africa | 1 | 2017 | 10 | 0.150 |
Why?
| | Asia | 1 | 2017 | 19 | 0.150 |
Why?
| | Selection, Genetic | 1 | 2017 | 23 | 0.150 |
Why?
| | Brazil | 1 | 2017 | 35 | 0.150 |
Why?
| | RNA Stability | 1 | 2017 | 23 | 0.150 |
Why?
| | Clostridium thermocellum | 1 | 2017 | 3 | 0.140 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 93 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2018 | 75 | 0.140 |
Why?
| | Recombination, Genetic | 1 | 2017 | 106 | 0.140 |
Why?
| | Virulence | 1 | 2017 | 168 | 0.140 |
Why?
| | Bayes Theorem | 1 | 2017 | 107 | 0.140 |
Why?
| | Viruses | 1 | 2017 | 22 | 0.140 |
Why?
| | Base Sequence | 1 | 2017 | 639 | 0.130 |
Why?
| | Phylogeography | 1 | 2016 | 6 | 0.130 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 135 | 0.130 |
Why?
| | Phosphorylation | 1 | 2017 | 525 | 0.130 |
Why?
| | Heart Failure | 1 | 2022 | 528 | 0.130 |
Why?
| | Salmonella Infections, Animal | 1 | 2016 | 18 | 0.130 |
Why?
| | Animals | 8 | 2025 | 13124 | 0.130 |
Why?
| | Escherichia coli | 1 | 2017 | 190 | 0.130 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 48 | 0.130 |
Why?
| | Salmonella Infections | 1 | 2016 | 17 | 0.130 |
Why?
| | Pseudomonas fluorescens | 1 | 2015 | 4 | 0.130 |
Why?
| | Rhizosphere | 1 | 2015 | 5 | 0.130 |
Why?
| | Pseudomonas putida | 1 | 2015 | 5 | 0.130 |
Why?
| | Plant Roots | 1 | 2015 | 33 | 0.130 |
Why?
| | Comparative Genomic Hybridization | 1 | 2015 | 43 | 0.130 |
Why?
| | Filoviridae | 1 | 2015 | 5 | 0.130 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 192 | 0.120 |
Why?
| | Cell Line | 1 | 2017 | 988 | 0.120 |
Why?
| | Pregnancy | 2 | 2018 | 2452 | 0.110 |
Why?
| | Sequence Alignment | 2 | 2009 | 119 | 0.100 |
Why?
| | beta-Lactamases | 2 | 2022 | 16 | 0.100 |
Why?
| | Bacterial Proteins | 3 | 2021 | 367 | 0.090 |
Why?
| | Drug Resistance, Multiple, Bacterial | 2 | 2024 | 64 | 0.090 |
Why?
| | DNA Viruses | 1 | 2009 | 3 | 0.080 |
Why?
| | Time Factors | 2 | 2025 | 2935 | 0.080 |
Why?
| | Rats | 2 | 2025 | 3292 | 0.070 |
Why?
| | Mice | 3 | 2025 | 5687 | 0.070 |
Why?
| | Male | 5 | 2025 | 25907 | 0.070 |
Why?
| | Genome Size | 2 | 2017 | 9 | 0.070 |
Why?
| | Signal Transduction | 2 | 2025 | 1624 | 0.060 |
Why?
| | Rats, Inbred Lew | 1 | 2025 | 49 | 0.060 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2025 | 77 | 0.060 |
Why?
| | Sulbactam | 1 | 2024 | 5 | 0.060 |
Why?
| | Female | 3 | 2025 | 27081 | 0.060 |
Why?
| | Azabicyclo Compounds | 1 | 2024 | 11 | 0.060 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2024 | 21 | 0.060 |
Why?
| | Receptors, Cell Surface | 1 | 2024 | 116 | 0.050 |
Why?
| | Proteasome Inhibitors | 1 | 2024 | 104 | 0.050 |
Why?
| | Siderophores | 1 | 2022 | 5 | 0.050 |
Why?
| | Republic of Korea | 1 | 2022 | 89 | 0.050 |
Why?
| | Proteins | 1 | 2005 | 339 | 0.050 |
Why?
| | Computational Biology | 2 | 2017 | 215 | 0.050 |
Why?
| | Carbohydrates | 1 | 2022 | 38 | 0.050 |
Why?
| | Enterobacter | 1 | 2021 | 6 | 0.050 |
Why?
| | Self Care | 1 | 2022 | 135 | 0.050 |
Why?
| | DNA Methylation | 1 | 2025 | 550 | 0.040 |
Why?
| | Sarcopenia | 1 | 2020 | 95 | 0.040 |
Why?
| | Amino Acids | 1 | 2022 | 373 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 1808 | 0.040 |
Why?
| | Introns | 2 | 2009 | 48 | 0.040 |
Why?
| | Thailand | 1 | 2018 | 8 | 0.040 |
Why?
| | Specimen Handling | 1 | 2018 | 55 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 22 | 0.040 |
Why?
| | Multilocus Sequence Typing | 1 | 2018 | 14 | 0.040 |
Why?
| | Feces | 1 | 2018 | 134 | 0.040 |
Why?
| | Temperature | 1 | 2018 | 162 | 0.040 |
Why?
| | Gene Dosage | 1 | 2018 | 74 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2018 | 144 | 0.040 |
Why?
| | Bacterial Toxins | 1 | 2018 | 51 | 0.040 |
Why?
| | Clostridium Infections | 1 | 2018 | 55 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 1610 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2018 | 574 | 0.030 |
Why?
| | Molecular Sequence Data | 1 | 2018 | 778 | 0.030 |
Why?
| | Mutation | 1 | 2022 | 1280 | 0.030 |
Why?
| | Spatio-Temporal Analysis | 1 | 2016 | 9 | 0.030 |
Why?
| | Molecular Typing | 1 | 2016 | 10 | 0.030 |
Why?
| | Swine Diseases | 1 | 2016 | 6 | 0.030 |
Why?
| | Molecular Epidemiology | 1 | 2016 | 36 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2020 | 772 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 27 | 0.030 |
Why?
| | Swine | 1 | 2016 | 408 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 475 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2018 | 2749 | 0.020 |
Why?
| | Mammals | 1 | 2009 | 50 | 0.020 |
Why?
| | Baculoviridae | 1 | 2009 | 5 | 0.020 |
Why?
| | Phycodnaviridae | 1 | 2009 | 2 | 0.020 |
Why?
| | Gene Transfer, Horizontal | 1 | 2009 | 7 | 0.020 |
Why?
| | Poxviridae | 1 | 2009 | 7 | 0.020 |
Why?
| | Herpesviridae | 1 | 2009 | 17 | 0.020 |
Why?
| | Exons | 1 | 2009 | 93 | 0.020 |
Why?
| | Aged | 1 | 2022 | 9741 | 0.020 |
Why?
| | Middle Aged | 1 | 2022 | 12611 | 0.020 |
Why?
|
|
Jun's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|